StemCell Institute Inc. (TYO:7096)

Market Cap	10.96B
Revenue (ttm)	2.68B
Net Income (ttm)	385.00M
Shares Out	10.25M
EPS (ttm)	37.59
PE Ratio	28.46
Forward PE	n/a
Dividend	25.00 (2.37%)
Ex-Dividend Date	Sep 27, 2024

Volume	31,200
Average Volume	54,790
Open	1,044.00
Previous Close	1,056.00
Day's Range	1,041.00 - 1,080.00
52-Week Range	998.00 - 1,923.00
Beta	0.59
RSI	41.58
Earnings Date	Aug 4, 2025

About StemCell Institute

StemCell Institute Inc. engages in the stem cell banking business in Japan. The company is also involved in research and development of medical treatments using stem cells, as well as engages in banking of blood vessel cells businesses. StemCell Institute Inc. was incorporated in 1999 and is headquartered in Tokyo, Japan. StemCell Institute Inc. is a subsidiary of Trim Medical Holdings Inc.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1999
• Employees: 98
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 7096

Financial Performance

In 2024, StemCell Institute's revenue was 2.68 billion, an increase of 7.98% compared to the previous year's 2.48 billion. Earnings were 385.00 million, an increase of 24.19%.